These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17786348)

  • 1. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
    Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
    Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
    Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.
    Fang WK; Gu W; Li EM; Wu ZY; Shen ZY; Shen JH; Wu JY; Pan F; Lv Z; Xu XE; Huang Q; Xu LY
    Hum Pathol; 2010 Oct; 41(10):1456-65. PubMed ID: 20621329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
    J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
    Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II alpha expression in esophageal squamous cell carcinoma.
    Ohashi Y; Sasano H; Yamaki H; Shizawa S; Kikuchi A; Shineha R; Akaishi T; Satomi S; Nagura H
    Anticancer Res; 1999; 19(3A):1873-80. PubMed ID: 10470130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
    Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
    J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma.
    Furihata M; Ishikawa T; Inoue A; Yoshikawa C; Sonobe H; Ohtsuki Y; Araki K; Ogoshi S
    Clin Cancer Res; 1996 Oct; 2(10):1781-5. PubMed ID: 9816130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification.
    Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K
    Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.